DailySand tracks cannabis rescheduling across AI, semiconductor infrastructure, capital markets, and critical minerals supply chains. Below are curated source items and daily digests where cannabis rescheduling appears in today's cross-sector intelligence briefing.
1 item across 1 digest
The DEA will hold an administrative hearing on June 29 to consider broader rescheduling of cannabis beyond the state-licensed medical market to Schedule III status, which would affect the entire adult-use commerce sector. This regulatory decision carries material implications for investment in cannabis-adjacent industries and compliance costs across supply chains.
Read original →
DailySand